Steroids and β2-agonists regulate hyaluronan metabolism in asthmatic airway smooth muscle cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 6, 2012, Pages 759-767

  Papakonstantinou, Eleni ^a   Klagas, Ioannis ^a   Karakiulakis, George ^a   Hostettler, Katrin ^b   S'ng, Chong Teck ^b   Kotoula, Vassiliki ^a   Savic, Spasenija ^b   Tamm, Michael ^b   Roth, Michael ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Asthma; Glucocorticoids; Glycosaminoglycans; Hyaluronan; Long acting 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; GLUCOSAMINE; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE;

ARTICLE; ASTHMA; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; METABOLISM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANTIGENS, CD44; ASTHMA; BUDESONIDE; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELLS, CULTURED; ETHANOLAMINES; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLUCOCORTICOIDS; GLUCURONOSYLTRANSFERASE; GLYCOSAMINOGLYCANS; GPI-LINKED PROTEINS; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MYOCYTES, SMOOTH MUSCLE; PROPRANOLOL; RESPIRATORY SYSTEM;

EID: 84870524075     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0101OC     Document Type: Article

References (42)

1. Grainge CL, Lau LC, Ward JA, Dulay V, Lahiff G, Wilson S, Holgate S, Davies DE, Howarth PH. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011;364:2006-2015.
2. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 2006;129:1068-1087.
3. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998;67:609-652.
4. Cavalcante FS, Ito S, Brewer K, Sakai H, Alencar AM, Almeida MP, Andrade JS Jr, Majumdar A, Ingenito EP, Suki B. Mechanical interactions between collagen and proteoglycans: implications for the stability of lung tissue. J Appl Physiol 2005;98:672-679.
5. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006;85:699-715.
6. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999;274:25085-25092.
7. Papakonstantinou E, Kouri FM, Karakiulakis G, Klangas I, Eickelberg O. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension. Eur Respir J 2008;32:1504-1512.
8. Pure E, Assoian RK. Rheostatic signaling by CD44 and hyaluronan. Cell Signal 2009;21:651-655.
9. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest 1995;95:1158-1168.
10. Klagas I, Goulet S, Karakiulakis G, Zhong J, Baraket M, Black JL, Papakonstantinou E, Roth M. Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. Eur Respir J 2009;34:616-628.
11. Johnson PR, Armour CL, Carey D, Black JL. Heparin and PGE2 inhibit DNA synthesis in human airway smooth muscle cells in culture. Am J Physiol Lung Cell Mol Physiol 1995;269:L514-L519.
12. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, Black JL. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001;164:474-477.
13. Goulet S, Bihl PM, Gambazzi F, Tamm M, Roth M. Opposite effect of corticosteroids and long-acting beta 2-agonists on serum- and TGF-beta1-induced extracellular matrix deposition by primary human lung fibroblasts. J Cell Physiol 2007;210:167-176.
14. Bracke KR, Dentener MA, Papakonstantinou E, Vernooy JH, Demoor T, Pauwels NS, Cleutjens J, van Suylen R, Joos GF, Brusselle GG, et al. Enhanced deposition of low weight hyaluronan in lungs of cigarette smoke-exposed mice. Am J Respir Cell Mol Biol 2010;42:753-761.
15. Tzellos TG, Batzios SP, Dionyssopoulos A, Karakiulakis G, Papakonstantinou E. Differential expression of matrix metalloproteinases and proteoglycans in juvenile hyaline fibromatosis. J Dermatol Sci 2011;61:94-100.
16. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-178.
17. Zuyderduyn S, Sukkar MB, Fust A, Dhaliwal S, Burgess JK. Treating asthma means treating airway smooth muscle cells. Eur Respir J 2008;32:265-274.
18. Halayko AJ, Amrani Y. Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003;137:209-222.
19. Hirst SJ. Regulation of airway smooth muscle cell immunomodulatory function: role in asthma. Respir Physiol Neurobiol 2003;137:309-326.
20. Lazaar AL, Panettieri RA Jr. Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy? Curr Opin Pharmacol 2001;1:259-264.
21. Johnson PR, Black JL, Carlin S, Ge Q, Underwood PA. The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. Am J Respir Crit Care Med 2000;162:2145-2151.
22. Burgess JK, Johnson PR, Ge Q, Au WW, Poniris HM, McParland EB, King G, Roth M, Black JL. Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2003;167:71-77.
23. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997;242:27-33.
24. Toole BP. Glycosaminoglycans and morphogenesis. In: Hay ED, editor. Cell biology and extracellular matrix. New York: Plenum Press; 1991. pp. 259-294.
25. Partsch G, Schwarzer C, Neumüller J, Dunky A, Petera P, Bröll H, Ittner G, Jantsch S. Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid. Z Rheumatol 1989;48:123-128.
26. Cantor JO, Cerreta JM, Armand G, Osman M, Turino GM. The pulmonary matrix, glycosaminoglycans and pulmonary emphysema. Connect Tissue Res 1999;40:97-104.
27. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007;23:435-461.
28. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science 2002;296:155-158.
29. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002;21:25-29.
30. Noble PW, Jiang D. Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc Am Thorac Soc 2006;3:401-404.
31. Aytekin M, Comhair SA, de la Motte C, Bandyopadhyay SK, Farver CF, Hascall VC, Erzurum SC, Dweik RA. High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2008;295:L789-L799.
32. Noble PW, McKee CM, Cowman M, Shin HS. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med 1996;183:2373-2378.
33. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J Clin Invest 1996;98:2403-2413.
34. Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol 1998;160:3023-3030.
35. Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, Belkin R, Yeh C, Secreto A, Assoian RK, Rader DJ. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest 2001;108:1031-1040.
36. Liang J, Jiang D, Jung Y, Xie T, Ingram J, Church T, Degan S, Leonard M, Kraft M, Noble PW. Role of hyaluronan and hyaluronan-binding proteins in human asthma. J Allergy Clin Immunol 2011;128:403-411.
37. Barnes PJ. Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 1998;158:123-132.
38. Lamyel F, Warnken-Uhlich M, Seemann WK, Mohr K, Kostenis E, Ahmedat AS, Smit M, Gosens R, Meurs H, Miller-Larsson A, et al. The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 2011;384:133-145.
39. Wang K, Liu CT, Wu YH, Feng YL, Bai HL, Ma ES, Wen FQ. Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma. Acta Pharmacol Sin 2011;32:126-132.
40. Kelly MM, O'Connor TM, Leigh R, Otis J, Gwozd C, Gauvreau GM, Gauldie J, O'Byrne PM. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol 2010;125:349-356.
41. Johnson JR, Pacitto SR, Wong J, Archer EW, Eirefelt S, Miller-Larsson A, Jordana M. Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction. Am J Physiol Lung Cell Mol Physiol 2008;295:L780-L788.
42. Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Effect of combining salmeterol and fluticasone on the progression of airway remodeling. Am J Respir Crit Care Med 2002;166:1128-1134.